✦ LIBER ✦

Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study

✍ Scribed by Tombal, Bertrand; Borre, Michael; Rathenborg, Per; Werbrouck, Patrick; Van Poppel, Hendrik; Heidenreich, Axel; Iversen, Peter; Braeckman, Johan; Heracek, Jiri; Baskin-Bey, Edwina; Ouatas, Taoufik; Perabo, Frank; Phung, De; Hirmand, Mohammad; Smith, Matthew R

Book ID: 122218378
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 622 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70129-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

674 Enzalutamide monotherapy: Results fr

674 Enzalutamide monotherapy: Results from a phase 2 study in hormone naive prostate cancer patients

✍ Tombal, B.; Borre, M.; Rathenborg, P.; Werbrouck, P.; Heidenreich, A.; Iversen, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Neoadjuvant bevacizumab, trastuzumab, an

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

✍ Jean-Yves Pierga; Thierry Petit; Thierry Delozier; Jean-Marc Ferrero; Mario Camp 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 188 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

Selumetinib in women with recurrent low-

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

✍ Farley, John; Brady, William E; Vathipadiekal, Vinod; Lankes, Heather A; Coleman 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 148 KB

209 POSTER An open-label, multicenter, p

209 POSTER An open-label, multicenter, phase 1/2 study of AT-101 in combination with docetaxel and prednisone in men with hormone refractory prostate cancer

✍ G. MacVicar; F.A. Greco; J. Reeves; B. Curti; B. Poiesz; B. Somer; K. Brill; L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

519 POSTER A phase 2, single-arm study o

519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer

✍ C.M. Matthews; S.N. Ho; M. Barve; K.M. Bell-McGuinn; L. Gilbert; R.T. Penson; E. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB